Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and Irinotecan in Advanced Esophageal or Gastric Cancer
NCT00003055Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 1997
- Primary completion
- Apr 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, irinotecan in esophageal cancer, gastric cancer (GC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 1997; status: completed.
02
Drugs
cisplatinirinotecan
03
Conditions
esophageal cancergastric cancer (GC)
Beyond the preview
Go deeper on NCT00003055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003055.